Mitchell Levine
2020
In 2020, Mitchell Levine earned a total compensation of $1.1M as Chief Financial Officer at Oncocyte Corp, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $131,670 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $721 |
| Option Awards | $504,431 |
| Salary | $361,999 |
| Stock Awards | $44,800 |
| Other | $14,839 |
| Total | $1,058,460 |
Levine received $504.4K in option awards, accounting for 48% of the total pay in 2020.
Levine also received $131.7K in bonus, $721 of change in pension value and nonqualified deferred compensation earnings, $362K in salary, $44.8K in stock awards and $14.8K in other compensation.
Rankings
In 2020, Mitchell Levine's compensation ranked 8,388th out of 13,090 executives tracked by ExecPay. In other words, Levine earned more than 35.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,388 out of 13,090 | 36th |
Division Manufacturing | 3,565 out of 5,621 | 37th |
Major group Chemicals And Allied Products | 1,444 out of 2,254 | 36th |
Industry group Drugs | 1,256 out of 1,954 | 36th |
Industry In Vitro and In Vivo Diagnostic Substances | 28 out of 60 | 53rd |
Source: SEC filing on May 21, 2021.
Levine's colleagues
We found three more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2020.